contact@asploro.com
Diabetes Research: Open Access
Dr. Lawrence A. Lavery

Dr. Lawrence A. Lavery

Professor with Tenure, Department of Plastic Surgery, University of Texas, Southwestern Medical Center, Dallas, Texas, USA

Email: lklavery@yahoo.com

Diabetes, Ulcers, Infections, Neuropathy and Osteomyelitis

Dr. Lawrence Lavery is a Professor in the Department of Plastic Surgery, as well as Director of Clinical Research in the Department of Plastic Surgery, at the University of Texas Southwestern Medical Center, Dallas, TX. His research group has published 210 peer reviewed papers and has received extramural funding from the Veterans Administration, the National Institute of Health, the Agency for Healthcare Research and Quality, the American Diabetes Association, and the American College of Foot and Ankle Surgeons.

Dr. Ahed J Alkhatib

Dr. Ahed J Alkhatib

Clinical researcher, department of forensic science and toxicology, faculty of medicine, Jordan University of Science and Technology, Jordan

Email: ajalkhatib@just.edu.jo

Setting medical hypotheses and writing book in different fields.

Other Research Interests: Neurology, Pharmacology, Philosophy of science, Tumor research, Behavioral biology, Emergency medicine

Dr. Ahed Alkhatib has finished his PhD from Cambell State University in 2011. I am currently working as a clinical researcher at faculty of medicine, Jordan University of Science and technology. Over the time, I have published more than 200 articles in various medical fields including neurosciences, pharmacology, and diabetes. My approaches in research include the involvement of philosophy of science in research which gives looking, and thinking in depth. I have developed several hypotheses in medicine such as the role of white matter in initiating diseases such as diabetes. In microbiology, I have demonstrated that prokaryotic cells and eukaryotic cells are similar in producing cell cycle proteins which can participate in autoimmunity diseases.

Dr. Serife M Kuskonmaz

Dr. Şerife Mehlika Kuşkonmaz

Department of Endocrinology and Metabolism, Gazi University Medical Faculty, Ankara 06510, Turkey

Email: mehlikaisildak@gmail.com

Diabetes treatment and side effects of antidiabetic medications, disorders of parathyroid, pituitary diseases.

Dr. Şerife Mehlika Kuşkonmaz was born in 1975 in Ankara. She was graduated from Hacettepe University Faculty of Medicine at 1999. She trained in Internal Medicine and in Endocrinology and Metabolism at Hacettepe University Hospital between 2000-2008. She worked in different medical centers as a specialist in the field of endocrinology, including Başkent University Hospital and Güven Hospital. Dr. Kuşkonmaz is now working as an associate professor in Ankara Research and Training Hospital Department of Endocrinology and Metabolism.

Dr. Clayton Dehn,PhD,

Dr. Clayton A. Dehn, M.S.

Vice President, Clinical Pharmacology Services, High Point Clinical Trials Center, 4160 Mendenhall Oaks Pkwy, Suite 105, High Point, NC 27265, USA

Email: mCADehn@yahoo.com; cdehn@highpointctc.com

General: Phlebotomy; I.V. Cannulation; Radioimmunoassay; Basic Life Support; Medical Emergencies in Clinical Research Units (MEiCRU); Advanced Cardiac Life Support (expired)

Metabolic and Cardiometabolic Glucose Clamps; Stable isotope dilution techniques; Max Pancreatic Stimulation / Suppression; Intravenous Glucose Tolerance Testing; Oral Glucose / Mixed Meal Tolerance Testing; Indirect Calorimetry; Flow Mediated Dilation; EndoPat; Peripheral vascular ultrasonography; De Novo Lipogenesis testing

Assisted Reproductive Techniques (ART) Artificial insemination; Sperm swim-up techniques; Advanced gamete staining techniques; Gamete and embryo freezing / vitrification; Embryo transfer; Reproductive ultrasonography; Computer Assisted Semen Analysis; Gamete micromanipulation; Intracytoplasmic Sperm Injection

Dr. Clayton Dehn, MS is a clinical research physiologist with domestic and international experience in the pharmaceutical and device development industry. He has particular expertise in endocrine disorders, especially those related to fertility and metabolic disturbances. He is a co-inventor of a process and substance for disturbing the inheritance pattern of ion-channelopathic disorders by selectively disabling genetically undesirable sperm cells. He is also the sole author of the first publication cautioning against the risk of SGLT-inhibition inducing ketoacidosis in insulinopenic populations.
Clay is an invited member of the Foundation for the National Institute of Health (FNIH) Non-Invasive Biomarkers of Metabolic Liver Disease (NIMBLE) consortium working toward the goal of identifying and validating non-invasive biomarker(s) that can eventually replace biopsy in the management of Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH). In that appointment, he serves as co-chair of both the Circulating Biomarkers Workstream and the Operational Sub-Team.

Dr. Victoria Serhiyenko,Ph.D

Dr. Victoria Serhiyenko

Assoc. Professor of the Department of Endocrinology Danylo Halytsky Lviv National Medical University, Lviv, Ukraine

Email: serhiyenkoa@gmail.com; serhiyenkov@gmail.com; serhiyenko@inbox.ru

Diabetes mellitus; Diabetes mellitus and Metabolism; Atherosclerosis; Cardiovascular complications of type 2 diabetes mellitus; Diabetic cardiomyopathy; Diabetic neuropathies; Diabetic cardiovascular autonomic neuropathy: pathogenesis, diagnostic and treatment.

Education:Higher, Department of internal medicine of Medical Faculty of Danylo Halytsky Lviv National Medical University. In 2010 defended Ph.D. thesis on “Metabolic and functional disorders in patients with type 2 diabetes mellitus and cardiomyopathy”, specialization “Endocrinology”, and in 2016, a doctoral dissertation titled “Cardiovascular autonomic neuropathy in patients with type 2 diabetes mellitus: pathogenesis, diagnosis, classification, prognostic value, treatment”. The author and co-author of 167 scientific publications, including eight monographs, a textbook and a manual “Endocrinology”, manuals “Urgent conditions in endocrinology” and “Endocrinology”.

Present position: Ph.D. in Medicine Sciences, DSc, Assoc. Professor of the Department of Endocrinology of Danylo Halytsky Lviv National Medical University.

Professional Society Memberships: Ukrainian Society for Endocrinology; Ukrainian Diabetic Federation. Member; European Association for the Study of Diabetes (Membership ID No 200679); European Atherosclerosis Society (Membership ID No: 55544638).

Dr. Hiroshi Bando

Dr. Hiroshi Bando, MD, Ph.D., FACP

Tokushima University / Medical Research, Nakashowa 1-61, Tokushima City 770-0943, Japan

Email: pianomed@bronze.ocn.ne.jp

Diabetes, Metabolic Syndrome, Primary Care Medicine, Complementary and Alternative Medicine (CAM), Integrative Medicine (IM), Music Therapy (MT), Sports Medicine.

Dr. Bando had graduated from Tokushima University, School of Medicine in 1981. After obtaining the ECFMG certificate, he participated in the family practice residency training in the United States. He got the degree of Doctors of Medicine in 1989 and engaged in the research of endocrine and metabolic medicine at Tokushima University. He has been a board member and specialist in several medical societies, such as diabetes, primary care, anti-aging medicine, integrative medicine (IM), music therapy and sports medicine. He was the chairperson of the 8th annual conference of Japanese Primary Care Association (JPCA) in 2017 with 4,500 attendees.